Document is current
Any future updates will be listed below
-
Authors
Cao, Yuling
Zheng, Suna
Zhang, Xiaoju
Yang, Yang
Peng, Jian
Jia, Lingying
Hu, Yan
-
Funding
Funding for this research was provided by:
The School of Nursing, Fudan University (No. FNF201929)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 19 February 2026
First Online: 3 March 2026
Declarations
:
: This study received ethical approval from the Institutional Review Board of Fudan University Shanghai Cancer Center (Approval No. IRB 2112248-24) and was conducted in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments. The study was registered in the Chinese Clinical Trial Registry (ChiCTR) on November 24, 2021 (Registration No. ChiCTR2100053559). Collaboration and support were provided by the chemotherapy departments or related units of all participating hospitals. Informed consent was obtained from all patients prior to the initiation of any study procedures.
: Not applicable.
: The authors declare no competing interests.
